Functional analysis of site-directed glycosylation mutants of the human equilibrative nucleoside transporter-2.
Article Details
- CitationCopy to clipboard
Ward JL, Leung GP, Toan SV, Tse CM
Functional analysis of site-directed glycosylation mutants of the human equilibrative nucleoside transporter-2.
Arch Biochem Biophys. 2003 Mar 1;411(1):19-26.
- PubMed ID
- 12590919 [ View in PubMed]
- Abstract
Protein glycosylation is important for nucleoside transport, and this has been demonstrated for the human equilibrative nucleoside transporter-1 (hENT1). It is not known whether glycosylation affects the functions of hENT2 or where hENT2 is glycosylated. We address these questions using N-glycosylation mutants (N48D, N57D, and N48/57D) and demonstrate that hENT2 is glycosylated at Asn(48) and Asn(57). Our results show that although the apparent affinities for [3H]uridine and [3H]cytidine of the mutants were indistinguishable from those of the wild-type protein, N-glycosylation was required for efficient targeting of hENT2 to the plasma membrane. All mutants had a two- to threefold increase in IC(50) for dipyridamole. N57D and N48/57D, but not N48D, also had a twofold increase in IC(50) for NBMPR. We conclude that the relative insensitivity of hENT2 to inhibitors is primarily due to its primary structure and not to glycosylation. Glycosylation modulates hENT1 function, but is not required for hENT2.